Consumer Health in Lithuania
Consumer health in 2024: The big picture
What next for consumer health?
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 2 Life Expectancy at Birth 2019-2024
Table 3 Sales of Consumer Health by Category: Value 2019-2024
Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 7 Penetration of Private Label by Category: % Value 2019-2024
Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Summary 1 Research Sources
Analgesics in Lithuania
Robust rises in 2024 although mainly due to price hikes
Marketing and promotions attract consumers as category remains led by international players
Solpadine suffers supply issues
Category growth looks set to be solid
Ibuprofen will maintain stronghold as overall category lacks innovation
Naproxen holds potential for expansion, while modern grocery retailers expand
Table 12 Sales of Analgesics by Category: Value 2019-2024
Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
Cough, Cold and Allergy (Hay Fever) Remedies in Lithuania
Low flu incidence undermines overall demand
Non-drowsy Opexa marches onwards
Moderate growth predicated for forecast period
Lack of innovation to persist, while decongest sprays gather further ground
Climate change continues to push up incidence of allergies
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
Dermatologicals in Lithuania
Convincing performance from dermatologicals in 2024
Female-oriented products and topical antifungals gain ground
Multinationals continue to lead, leaving little space for local players
Little change anticipated for dermatologicals
Cold sore treatments will continue to expand but vaginal antifungals has reached its peak
Out-of-home habits to support topical antiseptics while hair loss sales will benefit from innovation
Table 24 Sales of Dermatologicals by Category: Value 2019-2024
Table 25 Sales of Dermatologicals by Category: % Value Growth 2019-2024
Table 26 NBO Company Shares of Dermatologicals: % Value 2020-2024
Table 27 LBN Brand Shares of Dermatologicals: % Value 2021-2024
Table 28 Forecast Sales of Dermatologicals by Category: Value 2024-2029
Table 29 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
Digestive Remedies in Lithuania
Value growth driven by rising prices
A Menarini Industrie Farmaceutiche Riunite maintains overall leadership
Dosages increase as consumers seek sure results though volume sales remain limited by lack of significant innovation
Low but stable sales across category
Widespread reflux will support antacids, and ageing population will drive value growth
Limited local presence in competitive landscape
Table 30 Sales of Digestive Remedies by Category: Value 2019-2024
Table 31 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
Table 32 NBO Company Shares of Digestive Remedies: % Value 2020-2024
Table 33 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
Table 34 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
Table 35 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
Wound Care in Lithuania
Early summer bodes well for wound care
Sticking plasters/adhesive still largest subcategory
Private label expands within landscape led by multinationals.
Volume sales likely to stagnate
Private label will continue to steal share
Niche and premium products may rise slightly
Table 36 Sales of Wound Care by Category: Value 2019-2024
Table 37 Sales of Wound Care by Category: % Value Growth 2019-2024
Table 38 NBO Company Shares of Wound Care: % Value 2020-2024
Table 39 LBN Brand Shares of Wound Care: % Value 2021-2024
Table 40 Forecast Sales of Wound Care by Category: Value 2024-2029
Table 41 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
Sports Nutrition in Lithuania
Sports nutrition makes further gains in 2024
Sports protein-based products keep on rising
E-commerce is major channel for sports nutrition sales
Bright future anticipated for sports nutrition
Local players will maintain market presence amid expanding retail presence
Protein bars contain high potential, with e-commerce further strengthening its commanding lead in distribution
Table 42 Sales of Sports Nutrition by Category: Value 2019-2024
Table 43 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
Table 44 NBO Company Shares of Sports Nutrition: % Value 2020-2024
Table 45 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
Table 46 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
Table 47 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029
Dietary Supplements in Lithuania
Stable growth for dietary supplements
Fish oils goes from strength to strength and eye health sees further expansion
Direct selling remains relevant in a fragmented landscape
Only low growth predicted for dietary supplements
Private label will benefit from currently small presence within category
Combination products to see rising demand, while joint health holds potential
Table 48 Sales of Dietary Supplements by Category: Value 2019-2024
Table 49 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
Table 50 Sales of Dietary Supplements by Positioning: % Value 2019-2024
Table 51 NBO Company Shares of Dietary Supplements: % Value 2020-2024
Table 52 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
Table 53 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
Table 54 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029
Vitamins in Lithuania
Volume growth declines in 2024
Vitamin B rises as D falls
Valentis maintains leadership label remains strong
Moderate forecast period facing vitamins in Lithuania
Multivitamins will continue to be popular
Single vitamins face varied fortunes while multivitamins will see greater specificity
Table 55 Sales of Vitamins by Category: Value 2019-2024
Table 56 Sales of Vitamins by Category: % Value Growth 2019-2024
Table 57 Sales of Multivitamins by Positioning: % Value 2019-2024
Table 58 NBO Company Shares of Vitamins: % Value 2020-2024
Table 59 LBN Brand Shares of Vitamins: % Value 2021-2024
Table 60 Forecast Sales of Vitamins by Category: Value 2024-2029
Table 61 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029
Weight Management and Wellbeing in Lithuania
Decline for weight loss supplements continues into 2024
Direct selling offers sports nutrition to boost sales
Ozempic usage grows while slimming teas gains ground
Decline for weight loss supplements shows no sign of reversal
Direct selling to remain primary distribution channel
Slimming teas to see positive but low volume growth as consumers shift to healthier options
Table 62 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
Table 63 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
Table 64 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
Table 65 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
Table 66 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
Table 67 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029
Herbal/Traditional Products in Lithuania
Moderate growth posted in 2024
Eucarbon Herbal leads herbal digestive remedies brands, while Sinupret maintains overall category lead
Local player Valentis gains value share in 2024
Low growth ahead for herbal/traditional products in Lithuania
Sleep aids likely to see volume rises while Valentis benefits from strong reputation for paediatric solutions
Haemorrhoid treatments to maintain presence in herbal dermatologicals, and environmental focus could expand consumer base
Table 68 Sales of Herbal/Traditional Products: Value 2019-2024
Table 69 Sales of Herbal/Traditional Products: % Value Growth 2019-2024
Table 70 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
Table 71 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
Table 72 Forecast Sales of Herbal/Traditional Products: Value 2024-2029
Table 73 Forecast Sales of Herbal/Traditional Products: % Value Growth 2024-2029
Paediatric Consumer Health in Lithuania
Post-pandemic surge settles down
Ibuprofen still preferred product, with fish oil also popular
Continued shift towards products with a natural positioning
Moderate growth predicted for overall category
Vitamins and dietary supplements set to do well
No sign of new challengers
Table 74 Sales of Paediatric Consumer Health by Category: Value 2019-2024
Table 75 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
Table 76 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
Table 77 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029